Rowasa and Paxil drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Rowasa (mesalamine) and Paxil (paroxetine hydrochloride). Common drug interactions include headache among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Rowasa and Paxil. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Rowasa?
Rowasa has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 943 Rowasa users. Check the latest studies of Rowasa.
What is Paxil?
Paxil has active ingredients of paroxetine hydrochloride. It is often used in depression. eHealthMe is studying from 92,546 Paxil users. Check the latest studies of Paxil.
14 people who take Rowasa and Paxil together, and have interactions are studied.

What are the common drug interactions of Rowasa and Paxil, by gender? *:
female:
- Headache (pain in head)
- Muscular weakness (muscle weakness)
- Pain in extremity
- Nephritis interstitial (a kidney condition characterized by swelling in between the kidney tubules)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
- Haemorrhoids (a swollen vein or group of veins in the region of the anus)
- Hyperkeratosis (thickening of the outer layer of the skin)
- Muscle twitching
- Pharyngitis (inflammation of the pharynx, causing a sore throat)
male:
- Chronic kidney disease
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
What are the common drug interactions of Rowasa and Paxil, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Inflammatory bowel disease
- Malignant melanoma (skin cancer rises from melancytes)
- Pyelonephritis (inflammation of kidney caused by bacteria)
- Renal failure acute (rapid kidney dysfunction)
- Uveitis (inflammation of the uvea)
- Myalgia (muscle pain)
- Headache (pain in head)
- Muscular weakness (muscle weakness)
- Pain in extremity
40-49:
- Abdominal pain
50-59:
- Blood creatinine increased
- Blood urea increased
- Muscular weakness (muscle weakness)
- Myalgia (muscle pain)
- Pain in extremity
- Pyelonephritis (inflammation of kidney caused by bacteria)
- Renal failure acute (rapid kidney dysfunction)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Uveitis (inflammation of the uvea)
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
60+:
n/a
What are the existing conditions these people have? *
- Upper Respiratory Tract Infection: 11 people, 78.57%
- Kidney Infection (Pyelonephritis): 11 people, 78.57%
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 11 people, 78.57%
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 11 people, 78.57%
- Acne (skin problems that cause pimples): 11 people, 78.57%
- Pharyngitis (inflammation of the pharynx, causing a sore throat): 5 people, 35.71%
- Pain: 1 person, 7.14%
- Nausea (feeling of having an urge to vomit): 1 person, 7.14%
- High Blood Pressure: 1 person, 7.14%
- Stress And Anxiety: 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Rowasa and Paxil?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Rowasa and Paxil:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rowasa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Paxil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rowasa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Paxil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
How the study uses the data?
The study uses data from the FDA. It is based on mesalamine and paroxetine hydrochloride (the active ingredients of Rowasa and Paxil, respectively), and Rowasa and Paxil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Tysabri cause Enlarged Prostate? - now
- Could Austedo cause Joint Pain? - a second ago
- Could Astelin cause Nosebleed? - a second ago
- Drug interactions of Novolog and Meclizine - 9 seconds ago
- Tinnitus and Drowsiness - 17 seconds ago
- Could Glivec cause Aggression? - 25 seconds ago
- Drug interactions of Vitamins and Pseudoephedrine Hydrochloride - 28 seconds ago
- Could Vimpat cause Urinary Incontinence? - 48 seconds ago
- Could Chantix cause Back Pain Aggravated? - 52 seconds ago
- Could Chantix cause Blood Immunoglobulin G Increased? - a minute ago